Xcenda

Xcenda is a strategic global consultancy specializing in pharmaceutical commercialization, market access strategy, health economics and outcomes research (HEOR), real-world evidence generation, field reimbursement solutions, and value demonstration for life sciences companies. The company helps pharmaceutical manufacturers prove product value, maximize patient access, and enhance brand performance through data-driven strategies[1][2][4][8].

Founded in 1994 by Robert Mauch with the vision of shifting healthcare conversations toward demonstrating the value of medical interventions using rigorous evidence[3][8], Xcenda has become an industry leader in HEOR and market access consulting. It was acquired by AmerisourceBergen Corporation in April 2007 for approximately $25 million[6]. AmerisourceBergen rebranded as Cencora in 2023–2024.

As part of Cencora’s Manufacturer Solutions division[5], Xcenda continues to operate as a leading provider of strategic consulting services for biopharma clients worldwide.

The company does not have its own therapeutic pipeline but supports clients across all stages of drug development and commercialization.